Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

WGA Speeds Diagnosis of Devastating Seizure Disorder in Kids

Published: Fri, 17 Aug 2018 09:37:19 EDT
Whole-genome analysis looks more clinically and economically feasible for diagnosing newborns with a rare, but devastating, epilepsy syndrome, new research shows.
Medscape Medical News

Weight Gain Doesn't Diminish Benefits of Giving Up Smoking

Published: Fri, 17 Aug 2018 08:48:40 EDT
Risk for type 2 diabetes rises temporarily for people who gain weight when they quit smoking, but cardiovascular benefit stays steady regardless.
Medscape Medical News

AHA Advisory Recommends Healthy Eating, Not Just Variety

Published: Fri, 17 Aug 2018 08:09:54 EDT
The advice to 'eat a variety of foods' is outdated because studies show a more varied diet often included more unhealthy foods and was not linked with a healthier weight, an AHA advisory reports.
Medscape Medical News

Study Supports Newest Indication for IL6R Blockade in Giant Cell Arteritis

Published: Fri, 17 Aug 2018 07:45:03 EDT
New research confirms the association of a common variant in the gene that encodes the receptor for IL-6 with reduced risk for aortic aneurysm and supports the newest indication for IL6R blockade, giant cell arteritis.
Medscape Medical News
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


Fresh from GSK deal, Orchard raises $150M for multifront late-phase gene therapy push

Published: Mon, 13 Aug 2018 10:06:24 +0000
Orchard Therapeutics has raised $150 million (€132 million) to advance three gene therapies toward approval. The series C round continues a transformative year for Orchard defined by the acquisition of GlaxoSmithKline’s portfolio of approved and experimental rare disease gene therapies.

MD Anderson, Accelerator bake up Magnolia, an NYC biotech in neuroprotection, with $31M series A

Published: Fri, 10 Aug 2018 18:04:50 +0000
MD Anderson Cancer Center and Accelerator Life Science Partners have co-founded a new company, Magnolia Neurosciences, to develop a new class of targeted neuroprotective drugs discovered by the cancer center’s researchers.

UC Berkeley backs oral gene therapy company targeting the gut in $1.5M seed round

Published: Fri, 10 Aug 2018 13:12:33 +0000
A UC Berkeley-backed preclinical company, DNAlite Therapeutics, has gathered $1.5 million in seed money to pursue oral gene therapies that can slip through the mucus barrier that typically blocks access to the gastrointestinal tract.

Astellas absorbs U.K. ocular gene therapy player Quethera

Published: Fri, 10 Aug 2018 12:09:13 +0000
Japan’s Astellas Pharma has delved deeper into the gene therapy sector, picking up U.K. specialist Quethera for around $109 million.
Displaying results 21-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy